Annual EBITDA
-$72.99M$64.10M+46.76%
Summary
- Current Value
- As of today, GLUE annual EBITDA is -$72.99M, up +46.76% on
- Historical Performance
- GLUE annual EBITDA is down -3.17% over the past 3 years, and down -852.02% over the past 5 years
- All-Time High Comparison
- GLUE annual EBITDA is currently -852.02% below its historical high of -$7.67M set on
- 3-Year Low Comparison
- GLUE annual EBITDA is +46.76% above its 3-year low of -$137.09M reached on
- Sector Comparison
- GLUE annual EBITDA is higher than 22.31% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$72.99M | +46.8% | -3.2% | -852.0% | -852.0% | |
| Quarterly EBITDA | -$30.88M | -26.4% | -19.8% | -396.9% | -631.4% | |
| TTM EBITDA | $16.84M | +113.9% | +117.4% | +206.8% | +498.9% | |
| Price | $24.59 | +310.5% | +260.6% | – | – | |
| PE Ratio | 80.52 | – | – | – | – | |
| Annual Revenue | $75.62M | +100.0% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | -$0.98 | +62.6% | +38.1% | -459.2% | -459.2% | |
| -$81.11M | +43.4% | -11.3% | -948.1% | -948.1% | ||
| Annual Net Income | -$72.70M | +46.3% | +1.7% | -839.3% | -839.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$72.99M | at high | |
| 5Y | -$27.47M | N/A | -165.7% |
| All | -$7.67M | -852.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$137.09M | +46.8% | |
| 5Y | -$137.09M | +46.8% | |
| All | -$137.09M | +46.8% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$72.99M | +46.8% | |
| -$137.09M | -26.2% | |
| -$108.64M | -53.6% |
| Year | Value | Change |
|---|---|---|
| -$70.75M | -157.5% | |
| -$27.47M | -258.3% | |
| -$7.67M | - |
FAQ
What is the current annual EBITDA of GLUE?
As of today, GLUE annual EBITDA is -$72.99M
What is 1-year change in GLUE annual EBITDA?
GLUE annual EBITDA is up +46.76% year-over-year
What is 3-year change in GLUE annual EBITDA?
GLUE annual EBITDA is down -3.17% over the past 3 years
How far is GLUE annual EBITDA from its all-time high?
GLUE annual EBITDA is currently -852.02% below its historical high of -$7.67M set on December 31, 2019
How does GLUE annual EBITDA rank versus sector peers?
GLUE annual EBITDA is higher than 22.31% of companies in Healthcare sector
When is GLUE next annual earnings release?
The next annual earnings release for GLUE is on
Quarterly EBITDA
-$30.88M$17.45M-129.95%
Summary
- Current Value
- As of today, GLUE quarterly EBITDA is -$30.88M, down -129.95% on
- Historical Performance
- GLUE quarterly EBITDA is down -26.43% year-over-year, and down -19.75% over the past 3 years
- All-Time High Comparison
- GLUE quarterly EBITDA is currently -167.01% below its historical high of $46.08M set on
- 3-Year Low Comparison
- GLUE quarterly EBITDA is +13.82% above its 3-year low of -$35.83M reached on
- Sector Comparison
- GLUE quarterly EBITDA is higher than 13.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$30.88M | -129.9% | -26.4% | -19.8% | -396.9% | |
| Annual EBITDA | -$72.99M | – | +46.8% | -3.2% | -852.0% | |
| TTM EBITDA | $16.84M | -27.7% | +113.9% | +117.4% | +206.8% | |
| Price | $24.59 | +190.7% | +310.5% | +260.6% | – | |
| PE Ratio | 80.52 | +190.7% | – | – | – | |
| Quarterly Revenue | $12.77M | -45.0% | +38.5% | +100.0% | +100.0% | |
| Quarterly EPS | -$0.33 | -119.7% | -13.0% | +43.8% | -123.6% | |
| -$32.98M | -112.0% | -24.3% | -16.3% | -416.4% | ||
| Quarterly Net Income | -$27.08M | -120.3% | -13.5% | +0.9% | -312.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $46.08M | -167.0% | |
| 3Y | $46.08M | -167.0% | |
| 5Y | $46.08M | -167.0% | |
| All | $46.08M | -167.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$30.88M | at low | |
| 3Y | -$35.83M | +13.8% | |
| 5Y | -$35.83M | +13.8% | |
| All | -$35.83M | +13.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GLUE?
As of today, GLUE quarterly EBITDA is -$30.88M
What is GLUE quarterly EBITDA most recent change?
GLUE quarterly EBITDA was down -129.95% on September 30, 2025
What is 1-year change in GLUE quarterly EBITDA?
GLUE quarterly EBITDA is down -26.43% year-over-year
How far is GLUE quarterly EBITDA from its all-time high?
GLUE quarterly EBITDA is currently -167.01% below its historical high of $46.08M set on March 31, 2025
How does GLUE quarterly EBITDA rank versus sector peers?
GLUE quarterly EBITDA is higher than 13.73% of companies in Healthcare sector
When is GLUE next earnings release?
The next earnings release for GLUE is on
TTM EBITDA
$16.84M$6.46M-27.71%
Summary
- Current Value
- As of today, GLUE TTM EBITDA is $16.84M, down -27.71% on
- Historical Performance
- GLUE TTM EBITDA is up +113.91% year-over-year, and up +117.43% over the past 3 years
- All-Time High Comparison
- GLUE TTM EBITDA is currently -27.71% below its historical high of $23.30M set on
- 3-Year Low Comparison
- GLUE TTM EBITDA is +112.28% above its 3-year low of -$137.09M reached on
- Sector Comparison
- GLUE TTM EBITDA is higher than 77.51% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $16.84M | -27.7% | +113.9% | +117.4% | +206.8% | |
| Annual EBITDA | -$72.99M | – | +46.8% | -3.2% | -852.0% | |
| Quarterly EBITDA | -$30.88M | -129.9% | -26.4% | -19.8% | -396.9% | |
| Price | $24.59 | +190.7% | +310.5% | +260.6% | – | |
| PE Ratio | 80.52 | +190.7% | – | – | – | |
| TTM Revenue | $181.54M | +2.0% | +1112.3% | +100.0% | +100.0% | |
| TTM EPS | $0.31 | -11.0% | +116.7% | +114.1% | +183.3% | |
| $8.51M | -43.1% | +106.6% | +108.2% | +152.9% | ||
| TTM Net Income | $20.95M | -13.3% | +117.5% | +120.7% | +229.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $23.30M | -27.7% | |
| 3Y | $23.30M | -27.7% | |
| 5Y | $23.30M | -27.7% | |
| All | $23.30M | -27.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$72.99M | N/A | +123.1% |
| 3Y | -$137.09M | +112.3% | |
| 5Y | -$137.09M | +112.3% | |
| All | -$137.09M | +112.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GLUE?
As of today, GLUE TTM EBITDA is $16.84M
What is GLUE TTM EBITDA most recent change?
GLUE TTM EBITDA was down -27.71% on September 30, 2025
What is 1-year change in GLUE TTM EBITDA?
GLUE TTM EBITDA is up +113.91% year-over-year
How far is GLUE TTM EBITDA from its all-time high?
GLUE TTM EBITDA is currently -27.71% below its historical high of $23.30M set on June 30, 2025
How does GLUE TTM EBITDA rank versus sector peers?
GLUE TTM EBITDA is higher than 77.51% of companies in Healthcare sector
When is GLUE next earnings release?
The next earnings release for GLUE is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- GLUE Official Website www.monterosatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1826457/000119312525268045/0001193125-25-268045-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1826457/000095017025042344/0000950170-25-042344-index.htm
- GLUE Profile on Yahoo Finance finance.yahoo.com/quote/GLUE
- GLUE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/glue